Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.83M Buy
56,761
+694
+1% +$80.1K 0.28% 71
2025
Q4
$5.9M Sell
56,067
-405
-0.7% -$38K 0.25% 68
2025
Q3
$4.74M Buy
56,472
+866
+2% +$71.3K 0.2% 87
2025
Q2
$4.4M Buy
55,606
+2,286
+4% +$182K 0.22% 89
2025
Q1
$4.79M Buy
53,320
+6,451
+14% +$602K 0.26% 85
2024
Q4
$4.66M Buy
46,869
+6,784
+17% +$699K 0.26% 80
2024
Q3
$4.55M Buy
40,085
+4,603
+13% +$547K 0.27% 83
2024
Q2
$4.39M Sell
35,482
-479
-1% -$61.7K 0.28% 76
2024
Q1
$4.75M Buy
+35,961
New +$4.43M 0.32% 67

Other funds holding MRK

Trajan Wealth's MRK Position: Q1 2026 in Review

Trajan Wealth increased its Merck (MRK) stake by 1.2% in Q1 2026, buying an estimated $80.1K and bringing the position to 56,761 shares worth $6.83M. The position accounts for 0.28% of the portfolio, ranked #71.

Trajan Wealth first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. 3,783 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Trajan Wealth held 56,761 shares of Merck worth $6.83M as of Q1 2026.
  • Trajan Wealth bought 694 Merck shares in Q1 2026, an estimated $80.1K.
  • Merck made up 0.28% of Trajan Wealth's portfolio in Q1 2026, its #71 holding.
  • Trajan Wealth first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • 3,783 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Trajan Wealth's 13F filing for Q1 2026, filed 14 May 2026.